tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Richard Law, 27 are a HOLD (58.7%), 18 are a BUY (39.13%), 1 are a SELL (2.17%).
Analyst Richard Law works at GOLDMAN SACHS with a stock forecast success ratio of 29.98% fulfilled within 70.55 days on average. Previously, Richard Law worked at CREDIT SUISSE.
Richard Law’s has documented 93 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OLMA, Olema Pharmaceuticals at 02-Apr-2024.
Analyst best performing recommendations are on FIXX (HOMOLOGY MEDICINES).
The best stock recommendation documented was for FIXX (HOMOLOGY MEDICINES) at 5/17/2022. The price target of $2.1 was fulfilled within 21 days with a profit of $0.59 (39.07%) receiving and performance score of 18.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
87
$52.1 (149.28%)
90
8 days ago
3/12 (25%)
$52.28 (150.58%)
161
Buy
60
$25.1 (71.92%)
26
1 months 25 days ago
2/5 (40%)
$14.02 (30.49%)
89
Buy
90
$55.1 (157.88%)
95
1 months 26 days ago
0/3 (0%)
$44.06 (95.91%)
Buy
59
$24.1 (69.05%)
33
1 months 26 days ago
9/12 (75%)
$13.06 (28.43%)
135
Hold
55
$20.1 (57.59%)
36
2 months 9 days ago
4/11 (36.36%)
$5.63 (11.40%)
92
Which stock is Richard Law is most bullish on?
What Year was the first public recommendation made by Richard Law?
